Revolutionizing Transplants: Gene-Edited Pig Organs Enter Human Trials

Gene-edited pig organs from specially-raised pigs are being used in pioneering transplantation research. At a high-security farm in the Blue Ridge mountains, Revivicor Inc. clones pigs with modified genes to provide organs for human transplants. The industry aims to alleviate the severe shortage of human organ donors, with clinical trials expected soon.

Gene-edited pig organs from specially-raised pigs are being used in pioneering transplantation research. At a high-security research farm in the Blue Ridge mountains, cloned pigs with modified genes aimed at providing organs for human transplants are developed by Revivicor Inc.

David Ayares of Revivicor Inc. described the stringent biosecurity measures in place to protect these valuable animals and ensure they remain contaminant-free. The company focuses on pioneering gene-editing techniques to reduce organ rejection and size mismatches.

An advanced $75 million pathogen-free facility in Christiansburg, Virginia, is raising pigs for xenotransplantation studies, aspiring to address the severe shortage of human organ donors. Clinical trials are imminent pending FDA evaluations and further animal research.